<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Pantherna Therapeutics GmbH and PROVIREX Genome Editing Therapies GmbH are developing lipid-based delivery systems for mRNA-directed genome editing of lymphocytes for the treatment of HIV and other life-threatening persistent viral diseases	</title>
	<atom:link href="https://www.pantherna-therapeutics.com/pantherna-therapeutics-gmbh-and-provirex-genome-editing-therapies-gmbh-are-developing-lipid-based-delivery-systems-for-mrna-directed-genome-editing-of-lymphocytes-for-the-treatment-of-hiv-and-other-li/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.pantherna-therapeutics.com/pantherna-therapeutics-gmbh-and-provirex-genome-editing-therapies-gmbh-are-developing-lipid-based-delivery-systems-for-mrna-directed-genome-editing-of-lymphocytes-for-the-treatment-of-hiv-and-other-li/</link>
	<description>We restore endothelial cell function.</description>
	<lastBuildDate>Mon, 07 Mar 2022 15:31:19 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.1</generator>
</channel>
</rss>
